InsiderClue
Stocks · Health care · Pharmaceutical Preparations

Bicara Therapeutics Inc.

BCAX Clue Score37
United States Fiscal year ends December CIK 0002023658 Results filed 11 Aug 2026
Add to watchlist

What the insiders did Net buying

Individual transactions

54
Insider
Date
Role
Action
Shares
Price
Amount
Ryan Cohlhepp
8 Sep 2026
President, COO & Interim CEO
Sold after exercise
3,442
$23.43
$80.66K
Ryan Cohlhepp
8 Sep 2026
President, COO & Interim CEO
Sold after exercise
14,058
$22.77
$320.05K
Ryan Cohlhepp
10 Aug 2026
President and COO
Sold after exercise
18,750
$27.98
$524.53K
Claire Mazumdar
10 Aug 2026
Chief Executive Officer
Sold after exercise
10,000
$27.98
$279.75K
Ivan Hyep
10 Aug 2026
Chief Financial Officer
Sold after exercise
12,500
$27.97
$349.59K
Claire Mazumdar
10 Jul 2026
Chief Executive Officer
Sold after exercise
28
$29.68
$831.04
Claire Mazumdar
10 Jul 2026
Chief Executive Officer
Sold after exercise
9,972
$28.42
$283.37K
Ivan Hyep
8 Jul 2026
Chief Financial Officer
Sold after exercise
830
$30.31
$25.16K
Ivan Hyep
8 Jul 2026
Chief Financial Officer
Sold after exercise
4,413
$29.82
$131.62K
Ivan Hyep
8 Jul 2026
Chief Financial Officer
Sold after exercise
22,757
$28.60
$650.90K
Ryan Cohlhepp
8 Jul 2026
President and COO
Sold after exercise
1,075
$30.35
$32.63K
Ryan Cohlhepp
8 Jul 2026
President and COO
Sold after exercise
4,306
$29.80
$128.30K
Ryan Cohlhepp
8 Jul 2026
President and COO
Sold after exercise
22,833
$28.76
$656.65K
Ivan Hyep
21 May 2026
Chief Financial Officer
Sold after exercise
9,200
$20.42
$187.88K
Claire Mazumdar
18 May 2026
Chief Executive Officer
Sold after exercise
2,978
$20.35
$60.60K
Claire Mazumdar
18 May 2026
Chief Executive Officer
Sold after exercise
12,022
$19.96
$239.98K
Ryan Cohlhepp
15 May 2026
President and COO
Sold after exercise
4,500
$20.29
$91.31K
Ryan Cohlhepp
15 May 2026
President and COO
Sold after exercise
8,000
$20.29
$162.34K
David Raben
27 Apr 2026
Chief Medical Officer
Sold after exercise
5,500
$22.88
$125.83K
Ivan Hyep
21 Apr 2026
Chief Financial Officer
Sold after exercise
9,200
$23.00
$211.61K
Claire Mazumdar
20 Apr 2026
Chief Executive Officer
Sold after exercise
15,000
$23.61
$354.15K
Ryan Cohlhepp
15 Apr 2026
President and COO
Sold after exercise
4,500
$23.01
$103.53K
Ryan Cohlhepp
15 Apr 2026
President and COO
Sold after exercise
8,000
$23.01
$184.06K
David Raben
25 Mar 2026
Chief Medical Officer
Sold after exercise
5,500
$18.95
$104.23K
Ivan Hyep
23 Mar 2026
Chief Financial Officer
Sold after exercise
9,200
$18.52
$170.35K
Claire Mazumdar
20 Mar 2026
Chief Executive Officer
Sold after exercise
1,596
$18.95
$30.25K
Claire Mazumdar
19 Mar 2026
Chief Executive Officer
Sold after exercise
6,905
$18.78
$129.70K
Claire Mazumdar
18 Mar 2026
Chief Executive Officer
Sold after exercise
6,499
$18.84
$122.41K
Ryan Cohlhepp
16 Mar 2026
President and COO
Sold after exercise
4,500
$19.66
$88.46K
Ryan Cohlhepp
16 Mar 2026
President and COO
Sold after exercise
8,000
$19.66
$157.26K
Claire Mazumdar
9 Mar 2026
Chief Executive Officer
Sold after exercise
36,766
$19.17
$704.66K
Claire Mazumdar
6 Mar 2026
Chief Executive Officer
Sold after exercise
3,817
$18.75
$71.57K
Claire Mazumdar
5 Mar 2026
Chief Executive Officer
Sold after exercise
1,786
$18.74
$33.46K
David Raben
4 Mar 2026
Chief Medical Officer
Sold after exercise
16,300
$18.52
$301.92K
Ivan Hyep
4 Mar 2026
Chief Financial Officer
Sold after exercise
2,963
$18.25
$54.06K
Claire Mazumdar
4 Mar 2026
Chief Executive Officer
Sold after exercise
2,631
$18.73
$49.29K
David Raben
3 Mar 2026
Chief Medical Officer
Sold after exercise
200
$18.45
$3.69K
Ivan Hyep
3 Mar 2026
Chief Financial Officer
Sold after exercise
13,555
$18.22
$246.91K
Ryan Cohlhepp
3 Mar 2026
President and COO
Sold after exercise
4,500
$18.16
$81.73K
Ryan Cohlhepp
3 Mar 2026
President and COO
Sold after exercise
12,892
$18.16
$234.16K
Ryan Cohlhepp
25 Feb 2026
President and COO
Sold after exercise
523
$18.04
$9.43K
Ryan Cohlhepp
25 Feb 2026
President and COO
Sold after exercise
3,108
$18.04
$56.07K
Ivan Hyep
22 Jan 2026
Chief Financial Officer
Sold after exercise
1,882
$18.15
$34.16K
Ivan Hyep
22 Dec 2025
Chief Financial Officer
Sold after exercise
9,200
$18.31
$168.49K
Ryan Cohlhepp
15 Dec 2025
President and COO
Sold after exercise
4,500
$18.68
$84.08K
Ryan Cohlhepp
15 Dec 2025
President and COO
Sold after exercise
8,000
$18.68
$149.47K
David Raben
25 Nov 2025
Chief Medical Officer
Sold after exercise
906
$18.84
$17.07K
David Raben
25 Nov 2025
Chief Medical Officer
Sold after exercise
4,594
$18.84
$86.56K
David Raben
24 Nov 2025
Chief Medical Officer
Sold after exercise
5,500
$18.45
$101.48K
Claire Mazumdar
24 Nov 2025
Chief Executive Officer
Sold after exercise
41,163
$18.86
$776.43K
Ivan Hyep
24 Nov 2025
Chief Financial Officer
Sold after exercise
17,795
$18.55
$330.09K
Ryan Cohlhepp
21 Nov 2025
President and COO
Sold after exercise
4,500
$18.05
$81.21K
Ryan Cohlhepp
21 Nov 2025
President and COO
Sold after exercise
8,000
$18.05
$144.38K
Ivan Hyep
21 Nov 2025
Chief Financial Officer
Sold after exercise
605
$18.15
$10.98K
Show all 64 transactions →

What was left out

Form 4 filings counted 53
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 2
Sales on a Rule 10b5-1 plan 3
Sales straight out of an exercise 54
Sales at will 0
Transactions with no price 0
Shares from compensation/vesting 496,312
History held since 16 Sep 2024